{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-25-003453","form_type":"8-K","ticker":"UEEC","cik":"0001096938","company_name":"United Health Products, Inc.","filed_at":"2025-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.511857+00:00","generated_at":"2026-05-22T03:06:26.058159+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"United Health Products uplisted to OTCQB; FDA declines IDE for CelluSTAT study","bullets":["Common stock upgraded from OTC Pink to OTCQB effective May 1, 2025; ticker UEEC.","FDA declined to approve IDE for follow-on CelluSTAT clinical study, citing BIMO audit findings from initial 2019 study.","Company responded to audit findings in Oct 2024 and Apr 2025; teleconference with FDA scheduled within 10 days.","No assurance that FDA Premarket Approval for CelluSTAT will be granted."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-25-003453","json":"https://secwatch.observer/filing/0001477932-25-003453.json","markdown":"https://secwatch.observer/filing/0001477932-25-003453.md","text":"https://secwatch.observer/filing/0001477932-25-003453.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1096938/000147793225003453/0001477932-25-003453-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1096938/000147793225003453/ueec_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T03:06:26.058159+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}